APA (7th ed.) Citation

Ren, Y., Tan, H., Zhuang, J., Cheng, L., Yuan, L., Ji, L., . . . Liu, P. (2025). Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL. Annals of Hematology, 104(5), 2823. https://doi.org/10.1007/s00277-025-06412-z

Chicago Style (17th ed.) Citation

Ren, Yuhong, et al. "Polatuzumab Vedotin, Zanubrutinib and Rituximab (Pola-ZR) Achieved Rapid and Deep Response in Untreated Frail and Elderly DLBCL." Annals of Hematology 104, no. 5 (2025): 2823. https://doi.org/10.1007/s00277-025-06412-z.

MLA (9th ed.) Citation

Ren, Yuhong, et al. "Polatuzumab Vedotin, Zanubrutinib and Rituximab (Pola-ZR) Achieved Rapid and Deep Response in Untreated Frail and Elderly DLBCL." Annals of Hematology, vol. 104, no. 5, 2025, p. 2823, https://doi.org/10.1007/s00277-025-06412-z.